Student designs smart mobility aid for dementia sufferers

Latest articles

Peptide therapeutics company targets age-related disease

Gray Matter working with Insilico Medicine to identify peptide targets and accelerate development timeline for age-related disease therapies. Earlier this month, we brought you the...

Buck researchers provide a framework to study precision nutrigeroscience

One size doesn't fit all – a new research sub-specialty deals with the fact that health benefits from many forms of dietary restriction vary...

Accelerating antiaging research by hacking longevity

Bringing together aging researchers, developers and entrepreneurs, the Longevity Hackathon aims to build new tools, raise awareness and attract talent to the field. Kicking off...

X marks the spot for meaningful information on aging and cognition

Understanding chromosomal differences between men and women could be the X Factor when it comes to tackling cognitive decline. A new paper published in Jama...

Most read

Tree of Longevity – understanding how supplements work

Pathways? Hallmarks? Biomarkers? Understanding the longevity supplements lingo can help you make better choices for your healthspan. Longevity supplements differ from other 'generic supplements' as...

An antiaging supplement that also reduces appetite?

One for the AGEs: Juvify signs IP licensing deal with Buck Institute for GLYLO antiaging supplement that aims to reduce glycation. A researcher at the...

Berberine could be longevity’s “best-kept secret”

From tackling senescence to lowering blood sugar, berberine is the supplement with a host of tricks up its sleeves. Berberine is a bioactive compound found...

Editor's picks

Peptide therapeutics company targets age-related disease

Gray Matter working with Insilico Medicine to identify peptide targets and accelerate development timeline for age-related disease therapies. Earlier this month, we brought you the...

Buck researchers provide a framework to study precision nutrigeroscience

One size doesn't fit all – a new research sub-specialty deals with the fact that health benefits from many forms of dietary restriction vary...

Accelerating antiaging research by hacking longevity

Bringing together aging researchers, developers and entrepreneurs, the Longevity Hackathon aims to build new tools, raise awareness and attract talent to the field. Kicking off...

Click the globe for translations.

New smart mobility aid will allow people with dementia to live independently for longer and reduce strain on the care system.

According to Alzheimer’s Research UK, one million people in the UK will have dementia by 2025 and this will increase to two million by 2050 [1]. This increase is a real concern, especially as the care system is already under pressure.

Longevity.Technology: Dementia is a terrible, degenerative disease; it causes rapid memory loss and impaired cognition, as well as intellectual and physical malfunction and often severe and distressing personality changes. As dementia progresses in a person, their memory and thinking becomes more and more affected. The result is that the sufferer is forced to adjust how they do everyday tasks and eventually a carer will be needed to support them in their daily activities. Requiring more support can be difficult and upsetting, and in addition to negatively impacting confidence, self-esteem and independence, it can leave people living with dementia questioning their sense of identity.

Final year Industrial Design student James Bayliss has designed ‘AIDE’ – a smart mobility aid that helps people with dementia live independently and safely in their own homes for longer, whilst reducing the strain on the care system.

AIDE comprises a smart walking stick, a wall charger and a series of Bluetooth beacons placed around the home and works by tracking a person’s daily movements in their home and identifying any actions out of the ordinary. As the person moves around the house with the walking stick, the stick communicates data to the beacons and, using pattern recognition software and machine learning, this data is turned into a ‘behaviour map’.

AIDE can then identify unusual behaviour – for example, if a person is in the bathroom for much longer than usual, or if the stick moves in a certain manner, which may suggest a fall – and then alert the care network via an app so someone can make contact with the person with dementia.

AIDE
The AIDE walking stick with sensory handle.

“This system allows the care network to be able to intervene if something goes wrong without having to be present the whole time. It’s about creating a safety net,” explained Bayliss.

“In my early research, it became very clear from speaking to members of care networks for people with dementia that a cohesive approach to care is what allows people with dementia to feel comfortable in their own space and allow them to continue to align with their sense of self, and as an extension of this, their own independence.

Ovarian Longevity webinar

“Currently, the undertaking required to orchestrate and organise all of the independent actors that make up a care network is massively stressful for the primary carers and can feel very disjointed for the person with dementia – AIDE aims to streamline this.”

AIDE
AIDE components.

Several aspects of the electronic and mechanical functions have been prototyped and tested by Bayliss, including an adjustable code for fall detection and the accelerometer/gyroscope chip that allows the system to understand the orientation and movement of the walking stick. He now hopes to bring all the technology together into a fully functioning prototype and perfect the behavioural mapping and app.

Of what he ultimately hopes to achieve, Bayliss said: “This project is a product of a large amount of research and design development that has allowed me to understand and explore the problems and pain points that are experienced by people trying to retain independence within their own home whilst dealing with the progression of dementia.

“I would hope that this rigorous process has yielded a product proposal that could genuinely make a difference for both those who have dementia and the care network they have around them.”

AIDE is being exhibited as part of the Degree Show 2021. For more information on the Show, click here

Ovarian Longevity webinar

[1] https://www.dementiastatistics.org/statistics/prevalence-projections-in-the-uk/

Image and video courtesy of Loughborough University
Eleanor Garth
Deputy Editor Now a science and medicine journalist, Eleanor worked as a consultant for university spin-out companies and provided research support at Imperial College London and various London hospitals in a former life.

Most popular

Tree of Longevity – understanding how supplements work

Pathways? Hallmarks? Biomarkers? Understanding the longevity supplements lingo can help you make better choices for your healthspan. Longevity supplements differ from other 'generic supplements' as...

An antiaging supplement that also reduces appetite?

One for the AGEs: Juvify signs IP licensing deal with Buck Institute for GLYLO antiaging supplement that aims to reduce glycation. A researcher at the...

Berberine could be longevity’s “best-kept secret”

From tackling senescence to lowering blood sugar, berberine is the supplement with a host of tricks up its sleeves. Berberine is a bioactive compound found...

Spermidine: the mind-enhancing supplement

Scientists are finding that a high intake of dietary spermidine could slow down (or reverse) the brain aging process. Memory loss and slower brain function...

Related articles

Peptide therapeutics company targets age-related disease

Gray Matter working with Insilico Medicine to identify peptide targets and accelerate development timeline for age-related disease therapies. Earlier this month, we brought you the...

Shifting gear: startup aims to de-risk rejuvenation therapy

Shift Bioscience raising funding to develop safe cellular reprogramming therapies for rejuvenation. DISCLOSURE: Longevity.Technology (a brand of First Longevity Limited) has been contracted by the...

Predicting possible Alzheimer’s with nearly 100% accuracy

Researchers develop a deep learning-based method that can predict the possible onset of Alzheimer's disease from brain images with an accuracy of over 99%. Researchers...

Longevity industry “taking shape”

ARDD 2021 kicks off: sessions to cover longevity topics from AI and senolytics to mitochondria and stem cell rejuvenation. Following yesterday’s workshops, ARDD 2021 really...

The need to educate in longevity

Lots to learn about longevity at ARDD 2021: from pharma and startups to physicians and high schoolers. This week, we’ll be bringing you a wealth...
Nutriop